Checkpoint inhibitor therapy for treating melanoma

08:21 EDT 6 Sep 2016 | ecancermedicalscience

Dr Weber speaks with ecancertv at WCCS 2016 about checkpoint inhibitor therapy for treating melanoma. He outlines ongoing and upcoming trials of PD-1/PD-L1 based immunotherapy, as well as immune modulation via OX40 and 41BB antibodies. Dr Weber also...

Original Article: Checkpoint inhibitor therapy for treating melanoma


More From BioPortfolio on "Checkpoint inhibitor therapy for treating melanoma"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...